Beneficial Ownership Report · SCHEDULE 13G
Accendra Health, Inc.
ACHNYSEEQUITYCurrent
Beneficial Ownership Report
Structured filing — SCHEDULE 13G
primary_doc.xml
Subject company
- Company
- ACCENDRA HEALTH INC/VA/
- Company CIK
- 0000075252
- Street
- 4435 WATERFRONT DRIVE
- Street (continued)
- SUITE 300
- City
- GLEN ALLEN
- State / country code
- VA
- Postal code
- 23060
Statement details
- Security class
- Common Stock
- Event date
- 09/30/2026
- Rule designation
- Rule 13d-1(b)
Reporting person 1
- Name
- BANK OF AMERICA CORP /DE/
- Citizenship / organization
- DE
- Reporting person type
- HC
- Group designation
- b
- Aggregate amount owned
- 8,270,614.00
- Percent of class
- 10.8
- Sole voting power
- 0.00
- Shared voting power
- 1,349,537.00
- Sole dispositive power
- 0.00
- Shared dispositive power
- 8,270,614.00
- Comments
- The beneficial ownership calculation relies on the 76,904,704 outstanding shares disclosed in the Form 10-Q by the issuer on August 10, 2026, which reports share totals as of June 30, 2026.
Item 1
Issuer
ACCENDRA HEALTH INC/VA/
Principal executive office address
4435 WATERFRONT DRIVE, SUITE 300, GLEN ALLEN, VIRGINIA, 23060.
Item 2
Citizenship
Delaware
Filing person
BANK OF AMERICA CORP /DE/
Principal business or residence address
100 N TRYON ST CHARLOTTE, NC 28255
Item 3
Not applicable indication
N
Type of filing person
HC
Item 4
Percent of class
10.8%
Amount beneficially owned
8,270,614.00
Sole voting power
0.00
Shared voting power
1,349,537.00
Sole dispositive power
0.00
Shared dispositive power
8,270,614.00
Item 5
Not applicable indication
Y
Ownership of 5% or less
N
Item 6
Not applicable indication
Y
Item 7
Not applicable indication
N
Subsidiaries
This statement on Schedule 13G is being filed by Bank of America Corporation on behalf of itself and its wholly owned subsidiaries BofA Securities, Inc., a broker dealer registered under section 15 of the Act (15 U.S.C. 78o); Bank of America N.A., a bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); Merrill Lynch International, a non-U.S. institution in accordance with section 240.13d-1(b)(1)(ii)(J); and Merrill Lynch Pierce Fenner & Smith, Inc., a broker dealer registered under section 15 of the Act (15 U.S.C. 78o).
Item 8
Not applicable indication
Y
Item 9
Not applicable indication
Y
Item 10
Not applicable indication
N
Certifications
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
Signature 1
- Reporting person
- BANK OF AMERICA CORP /DE/
- Signed
- /s/ Monica Yako
- Title
- Authorized Signatory
- Date
- 10/07/2026
Filed exhibits
- POWER OF ATTORNEY ↗bac_poa.pdf
Company context
Accendra Health, Inc. (NYSE: ACH) is a leading nationwide provider of products, technology, and services that support health beyond the hospital for millions of people each year. We connect patients, providers, and insurers, delivering innovative solutions that help promote better health outcomes and improve quality of life for people living with chronic, complex health conditions. Backed by the industry-leading expertise of our Apria and Byram brands, Accendra Health is reimagining the future of home-based care. To learn more about our broad portfolio of essentials for diabetes, sleep health, wound care, respiratory care, urology, and ostomy, visit www.accendrahealth.com.
Current securities
Recent company filings
- Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing · Regulation FD DisclosureOct 9, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsSep 28, 2026
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure · Other EventsSep 17, 2026
- 144 filingSep 11, 2026
- Regulation FD DisclosureAug 17, 2026